TMD Wealth Management’s Perspective Therapeutics CATX Stock Holding History

TMD Wealth Management’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$8.04K	–	58
2023 Q4	$8.04K	Hold	2,000	–	–	﹤0.01%	57
2023 Q3	$5.47K	Hold	2,000	–	–	﹤0.01%	56
2023 Q2	$13.4K	Hold	2,000	–	–	﹤0.01%	52
2023 Q1	$12.8K	Hold	2,000	–	–	﹤0.01%	48
2022 Q4	$4.94K	Hold	2,000	–	–	﹤0.01%	42
2022 Q3	$5K	Hold	2,000	–	–	﹤0.01%	42
2022 Q2	$6K	Hold	2,000	–	–	﹤0.01%	40
2022 Q1	$7K	Hold	2,000	–	–	﹤0.01%	46
2021 Q4	$8K	Hold	2,000	–	–	﹤0.01%	50
2021 Q3	$13K	Hold	2,000	–	–	0.01%	43
2021 Q2	$16K	Hold	2,000	–	–	0.01%	39
2021 Q1	$22K	Hold	2,000	–	–	0.01%	40
2020 Q4	$9K	Buy	+2,000	New	+$8.84K	0.01%	37

Other funds holding CATX

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HBT

Hills Bank & Trust North Liberty, Iowa $2.35B AUM 17.18% 1-Year Est. Return

TMD Wealth Management's CATX Position: Q1 2024 in Review

TMD Wealth Management sold out of Perspective Therapeutics (CATX) in Q1 2024, closing a stake of 2,000 shares — an estimated $8.04K sold.

TMD Wealth Management first reported a position in CATX in Q4 2020 and held it in 13 quarters. The position peaked at $22K in Q1 2021. 103 funds tracked by Wall St. Rank hold CATX as of Q1 2024.

TMD Wealth Management reported no remaining Perspective Therapeutics position as of Q1 2024 after selling out during the quarter.
TMD Wealth Management sold 2,000 Perspective Therapeutics shares in Q1 2024, an estimated $8.04K.
TMD Wealth Management first reported a position in Perspective Therapeutics in Q4 2020 and held it in 13 quarters.
TMD Wealth Management's Perspective Therapeutics position peaked at $22K in Q1 2021.
103 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2024.

Based on TMD Wealth Management's 13F filing for Q1 2024, filed 14 May 2024.